This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) | MicrobiomeTrials
← Back to trials NCT07519395
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-04-08Est. Completion: 2027-03-09
Enrollment target: 420 participantsLocations GSK Investigational Site, Anniston, Alabama, United States GSK Investigational Site, Guntersville, Alabama, United States GSK Investigational Site, Mobile, Alabama, United States GSK Investigational Site, Saraland, Alabama, United States GSK Investigational Site, Phoenix, Arizona, United States GSK Investigational Site, Scottsdale, Arizona, United States GSK Investigational Site, Tempe, Arizona, United States GSK Investigational Site, Tucson, Arizona, United States GSK Investigational Site, Anaheim, California, United States GSK Investigational Site, Chula Vista, California, United States GSK Investigational Site, Coronado, California, United States GSK Investigational Site, Garden Grove, California, United States GSK Investigational Site, Lancaster, California, United States GSK Investigational Site, Lancaster, California, United States GSK Investigational Site, Los Angeles, California, United States GSK Investigational Site, Murrieta, California, United States Other microbiome trials you might be interested in Fibromyalgia Diet, Gluten-Free
The purpose of this study is to evaluate the efficacy of two diets - gluten-free and low-FODMAP diet- in relieving sympt…
Montreal, Canada Completed Jun 15, 2022
Constipation Probiotic Probiotic Intervention
Constipation is a prevalent gastrointestinal condition. Beyond simple lifestyle measures (e.g. increasing fibre intake, …
London, United Kingdom Completed Jul 20, 2026
GSK Investigational Site, Pasadena, California, United States
GSK Investigational Site, San Diego, California, United States
GSK Investigational Site, San Diego, California, United States
GSK Investigational Site, Sherman Oaks, California, United States
GSK Investigational Site, West Hills, California, United States
GSK Investigational Site, Aurora, Colorado, United States
GSK Investigational Site, Colorado Springs, Colorado, United States
GSK Investigational Site, Lone Tree, Colorado, United States
GSK Investigational Site, Brandon, Florida, United States
GSK Investigational Site, Clearwater, Florida, United States
GSK Investigational Site, Coral Gables, Florida, United States
GSK Investigational Site, Doral, Florida, United States
GSK Investigational Site, Hialeah, Florida, United States
GSK Investigational Site, Homestead, Florida, United States
GSK Investigational Site, Jacksonville, Florida, United States
GSK Investigational Site, Kissimmee, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami Beach, Florida, United States
GSK Investigational Site, Miami Lakes, Florida, United States
GSK Investigational Site, Miami Springs, Florida, United States
GSK Investigational Site, New Port Richey, Florida, United States
GSK Investigational Site, Ocala, Florida, United States
GSK Investigational Site, Orlando, Florida, United States
GSK Investigational Site, Orlando, Florida, United States
GSK Investigational Site, Palm Harbor, Florida, United States
GSK Investigational Site, Pembroke Pines, Florida, United States
GSK Investigational Site, Pembroke Pines, Florida, United States
GSK Investigational Site, Sunrise, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Decatur, Georgia, United States
GSK Investigational Site, Lawrenceville, Georgia, United States
GSK Investigational Site, Union City, Georgia, United States
GSK Investigational Site, Idaho Falls, Idaho, United States
GSK Investigational Site, Meridian, Idaho, United States
GSK Investigational Site, Morton, Illinois, United States
GSK Investigational Site, Oak Lawn, Illinois, United States
GSK Investigational Site, Ames, Iowa, United States
GSK Investigational Site, Houma, Louisiana, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Clinton Township, Michigan, United States
GSK Investigational Site, Flint, Michigan, United States
GSK Investigational Site, Hazelwood, Missouri, United States
GSK Investigational Site, Missoula, Montana, United States
GSK Investigational Site, Hartsdale, New York, United States
GSK Investigational Site, New Windsor, New York, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, North Massapequa, New York, United States
GSK Investigational Site, Richmond Hill, New York, United States
GSK Investigational Site, Rochester, New York, United States
GSK Investigational Site, Charlotte, North Carolina, United States
GSK Investigational Site, Fayetteville, North Carolina, United States
GSK Investigational Site, Greenville, North Carolina, United States
GSK Investigational Site, Rocky Mount, North Carolina, United States
GSK Investigational Site, Salisbury, North Carolina, United States
GSK Investigational Site, Winston-Salem, North Carolina, United States
GSK Investigational Site, Beavercreek, Ohio, United States
GSK Investigational Site, Columbus, Ohio, United States
GSK Investigational Site, Mentor, Ohio, United States
GSK Investigational Site, Norman, Oklahoma, United States
GSK Investigational Site, Tulsa, Oklahoma, United States
GSK Investigational Site, Harrisburg, Pennsylvania, United States
GSK Investigational Site, Pittsburgh, Pennsylvania, United States
GSK Investigational Site, Uniontown, Pennsylvania, United States
GSK Investigational Site, Chattanooga, Tennessee, United States
GSK Investigational Site, Chattanooga, Tennessee, United States
GSK Investigational Site, Johnson City, Tennessee, United States
GSK Investigational Site, Kingsport, Tennessee, United States
GSK Investigational Site, Knoxville, Tennessee, United States
GSK Investigational Site, Nashville, Tennessee, United States
GSK Investigational Site, Corsicana, Texas, United States
GSK Investigational Site, Georgetown, Texas, United States
GSK Investigational Site, Harlingen, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Mesquite, Texas, United States
GSK Investigational Site, Missouri City, Texas, United States
GSK Investigational Site, Pearland, Texas, United States
GSK Investigational Site, San Antonio, Texas, United States
GSK Investigational Site, Ogden, Utah, United States
GSK Investigational Site, Ogden, Utah, United States
GSK Investigational Site, Sandy City, Utah, United States
GSK Investigational Site, Lynchburg, Virginia, United States
GSK Investigational Site, Petersburg, Virginia, United States
GSK Investigational Site, Richmond, Virginia, United States Recruiting
Irritable Bowel Syndrome (IBS)
Randomized, single-blind, sham-controlled crossover study evaluating the efficacy and safety of transcutaneous auricular…
Multiple Locations Est. completion Dec 31, 2028